Molecular modeling approach in design of new scaffold of α-glucosidase inhibitor as antidiabetic drug
Open Access
- 8 April 2025
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 42, 101995
Abstract
No abstract availableKeywords
Funding Information
- University of Tehran
- INSF (96005880)
This publication has 21 references indexed in Scilit:
- Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An UpdateCurrent Pharmaceutical Design, 2019
- Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidaseBioorganic & Medicinal Chemistry Letters, 2017
- Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitorsEuropean Journal of Medicinal Chemistry, 2017
- Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitorsBioorganic & Medicinal Chemistry Letters, 2016
- Setting the Record Straight: The Origin of the Pharmacophore ConceptJournal of Chemical Information and Modeling, 2014
- Direct Starch Digestion by Sucrase‐Isomaltase and Maltase‐GlucoamylaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- Epidemic obesity and type 2 diabetes in AsiaThe Lancet, 2006
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Strategy of Computer-Aided Drug DesignCurrent Drug Targets - Infectious Disorders, 2003
- Molecular Mechanism inα-Glucosidase and GlucoamylaseBioscience, Biotechnology, and Biochemistry, 1997